STAT

MAY 20, 2025

… Online weight loss company Noom has begun offering smaller doses of compounded versions of Novo Nordisk’s Wegovy as the U.S. Noom offers its compounded semaglutide at a starting price of $149 for the first month. milligram vial of Wegovy or Zepbound costs $349, according to the Novo and Lilly websites.

Compounding

European Pharmaceutical Review

OCTOBER 24, 2023

billion in 2028, according to a report by Arizton. billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 percent up to 2028. This is projected to grow at the highest compound annual growth rate of 5.27 Having been valued at $27.04

Packaging

Pharmacy Times

AUGUST 18, 2022

Study results show a compound annual growth rate of 5.2% billion in revenue in 2021.

Compounding

European Pharmaceutical Review

OCTOBER 16, 2023

The ADC market is expected to grow at a compound annual growth rate (CAGR) of 20 percent between 2023 and 2028, the contract development and manufacturing organisation (CDMO) highlighted. Enhancing manufacturing capabilities The bioconjugates market is currently valued at $33 billion according to research by Lonza.

Compounding

European Pharmaceutical Review

MARCH 9, 2023

” Highly potent APIs are pharmacologically and biologically active compounds at low doses. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). Based on the latest report and data, HPAPI market size is expected to reach $32 billion by 2028.

Compounding

pharmaphorum

JUNE 27, 2022

per share if Tazverik hits $250 million in annual sales in four consecutive quarters before the end of 2026, and $0.70 if the drug is cleared for the second-line FL inflation before 1 January, 2028. Ipsen’s CVR offer includes $0.30 The post Ipsen beefs up in oncology, buying US biopharma Epizyme appeared first on.

Compounding

Pharmaceutical Technology

SEPTEMBER 15, 2022

According to GlobalData’s report, Paxlovid, the company’s small-molecule Covid-19 oral therapy, was shown to reduce Covid-19 infections by 32% in adults and is forecast to be the top-selling drug by total sales, generating $81bn between 2021 and 2028. AbbVie reported a 22.7% Bristol Myers Squibb (BMS) documented a 9.1%

Vaccines

European Pharmaceutical Review

FEBRUARY 8, 2023

Breyanzi will exhibit the largest compound annual growth rate (CAGR) at 30 percent, compared to Yescarta’s CAGR of 9 percent. Breyanzi is approved for DLBCL, and a label expansion is anticipated for expansions into marginal zone lymphoma (MZL) and mantle cell lymphoma (MCL) in 2026 and 2028, respectively. billion in 2031.

Labelling

pharmaphorum

AUGUST 2, 2022

The potential for ADCs to combine the best of both mAbs and small molecule drugs means that there has been high interest in developing a successful compound since the first successful clinical trial in 1983. Development of the compound was subsequently ended. Not all rosy.

Compounding

ISPE

MAY 16, 2023

According to a report by Grand View Research, the global blockchain technology market in healthcare is expected to grow at a compound annual growth rate (CAGR) of 66.1% from 2021 to 2028.

Compounding

Pharmaceutical Technology

DECEMBER 16, 2022

The endometriosis market is expected to grow from $1.05bn in 2020 to $2.72bn in 2030 at a compound annual growth rate (CAGR) of 10.0% This therapy is currently in Phase II development and is expected to launch in the US and 5EU in 2027 and 2028, respectively.

Compounding

Pharmaceutical Technology

MARCH 23, 2023

GlobalData analysts forecast the total revenue from Seagen products to be around $36bn from 2023 to 2028, with a 29.3% compound annual growth rate (CAGR) according to Pfizer’s risk-adjusted projection.

Chemotherapy

European Pharmaceutical Review

JUNE 27, 2022

According to the ClinicalTrials.gov trial registry, as of April 2022 3 there were 231 bsAbs in clinical trials and a recent industry report 4 predicts the global market revenue for these products will exceed $20 billion by 2028. Figure 1: Example of bi-specific formats. Labrijn AF, Janmaat ML, Reichert JM, Parren PWHI. Nat Rev Drug Discov.

Compounding

Impact Pharmaceutical Services

SEPTEMBER 15, 2023

Structure-based drug design has evolved, facilitating the exploration of novel chemical probes and lead compound potency, and molecular docking utilizes target structures to predict interactions and offers simplicity and speed. billion by 2028.

Documentation

Pharmaceutical Technology

AUGUST 12, 2022

By 2028, the market is expected to reach $25 billion, with a compound annual growth rate (CAGR) of 46.6%. Overall, the global CAR-T cell market for all indications was worth $1.7 billion in 2021 and is forecast to reach $2.4 billion by the end of 2022.

Immunization

Pharmaceutical Technology

FEBRUARY 13, 2023

This makes early R&D less risky, as many lead compounds are discontinued due to inadequate pharmacokinetic profiles and require excessively high dosages to be pharmaceutically active. GlobalData’s analyst consensus forecast database estimates peak annual sales for ARV-110 of $325 million in 2028.

Chemotherapy

The Physician Pharmacist

OCTOBER 5, 2023

But that's going to grow and compound over many, many, many years. And you know, what we're seeing now, Nathan has a lot of lenders, it used to be the 2028 36 rules, what they used to determine how much home someone could afford in terms of what they were willing to lend doesn't mean what their budget should be. That's $100,000, right.

Medical Schools

European Pharmaceutical Review

JUNE 5, 2024

billion in 2028. As such, the compound annual growth rate (CAGR) is expected to be 12.8 A report by the Business Research Company predicts that the small molecule injectable drugs market will value $355.14 percent up to this period.

Compounding

The FDA Law Blog

DECEMBER 3, 2023

CMS will send the final manufacturer invoice for discount liabilities accrued by then on April 30, 2028. A “specified drug” means, for 2021, an applicable drug that is produced, prepared, propagated, compounded, converted, or processed by a specified manufacturer. Final Guidance at 2.

Labelling

Pharmaceutical Technology

MAY 26, 2023

This high compound annual growth rate of 23.6% These figures are only expected to grow in the coming years, with sales forecasted to reach over $150 billion by 2028. was powered by the advent of immune-checkpoint inhibitors, added Chalk. GlobalData is the parent company of Pharmaceutical Technology.

Immunization

Drug Topics

JUNE 10, 2025

In an opinion piece written for the Wall Street Journal , Kennedy wrote, “Without removing the current members, the current Trump administration would not have been able to appoint a majority of new members until 2028.”

Immunization